{"id":"https://genegraph.clinicalgenome.org/r/e5061525-e2bc-4aec-b866-188938b7620bv1.1","type":"EvidenceStrengthAssertion","dc:description":"PMS2 was first reported in relation to AD Lynch Syndrome in 1994 (Nicolaides et al., PMID: 8072530). Lynch syndrome is a cancer-predisposing syndrome characterized by predisposition to a wide variety of cancers, including neoplasms of the digestive tract, urinary tract, kidney, endometrium, ovary, brain, and prostate, as well as sebaceous skin tumors, depending on the gene involved. Tumors may occur at any age but often arise at earlier ages in adults than the corresponding tumors in the general population (Orphanet). More recent studies suggest that PMS2 causes a small increased risk of colon and endometrial cancer compared with other Lynch syndrome genes and the risk of other Lynch syndrome tumors was unclear  (PMID: 30161022). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found a difference in inheritance pattern and phenotypic variability for two different PMS2 disorders. Therefore, the following disease entities have been split into multiple disease entities, autosomal recessive constitutional mismatch repair deficiency (CMMRD) (OMIM:619101, MONDO:0010159). The split curation for AR CMMRD has been curated separately from this curation for Lynch syndrome. Fifteen variants (e.g. missense, in-frame indel, frameshift, large deletion) that have been reported in 16 probands in 9 publications (PMIDs: 8072530, 16619239, 23012243, 31992580, 23709753, 27435373, 15887124, 15872200, 31860975) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be LOF. This gene-disease association is also supported by experimental evidence (e.g. animal models, expression studies, in vitro functional assays; 5.5 points) (PMIDs: 10753224, 34489406, 20624957, 27435373, 24027009). Heterologous PMS2 knock-out mice are susceptible to intestinal tumors located mainly in the small intestine when treated with exogenous carcinogen (PMID: 10753224). Mouse models with Pms2 knock-in of c.1993A>G, which is equivalent to human c.2002A>G, results in an attenuated form of both CMMRD in homozygous state and Lynch Syndrome in heterozygotes (PMID: 34489406). In summary, PMS2 is definitively associated with AD Lynch Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e5061525-e2bc-4aec-b866-188938b7620b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T18:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2022-12-30T22:22:31.043Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/706e484a-3d4f-473a-ace1-beb0558caabd","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/706e484a-3d4f-473a-ace1-beb0558caabd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16619239","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c31264e-86b3-41d4-adde-2092a1250a8e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.705+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA012596"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/706e484a-3d4f-473a-ace1-beb0558caabd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Negative IHC","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9a772f80-2f6d-4080-96b1-48cfa0e40cef","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a772f80-2f6d-4080-96b1-48cfa0e40cef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31992580","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e1397bd-129d-492d-bb16-2dc005fe96e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.2275+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA366736382"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d13eee9c-8355-42bd-8d20-7ab7d1319838","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d13eee9c-8355-42bd-8d20-7ab7d1319838_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31860975","allele":{"id":"https://genegraph.clinicalgenome.org/r/f5aeaee0-586b-4c37-8a99-aa5e55d6572c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.1577del (p.Asp526AlafsTer69)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130165"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d13eee9c-8355-42bd-8d20-7ab7d1319838_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunohistochemistry (IHC) staining was used to identify the function of PMS2 mutation","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4d902721-8097-4ebb-a23b-e70a91cf2f7a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d902721-8097-4ebb-a23b-e70a91cf2f7a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15872200","allele":{"id":"https://genegraph.clinicalgenome.org/r/758b5a1b-d342-46d5-92e3-c0be5c370412","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.2192_2196del (p.Leu731fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA011049"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/65c5eb3e-82be-4730-b21f-adf273cd3e6e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15887124","rdfs:label":"case report","family":{"id":"https://genegraph.clinicalgenome.org/r/65c5eb3e-82be-4730-b21f-adf273cd3e6e","type":"Family","rdfs:label":"case report","member":{"id":"https://genegraph.clinicalgenome.org/r/63126d6f-5401-4c27-afab-ea7801765ca0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15887124","rdfs:label":"IV-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/b60f61c9-d9ce-4b27-abdc-2f46b692c628","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.1021del (p.Arg341fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA009113"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9643f75d-d9bc-4b45-b022-71e143873f79_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15887124","allele":{"id":"https://genegraph.clinicalgenome.org/r/b60f61c9-d9ce-4b27-abdc-2f46b692c628"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/63126d6f-5401-4c27-afab-ea7801765ca0"}},{"id":"https://genegraph.clinicalgenome.org/r/b7c752f1-6007-48cd-8d17-4ed7e2b62bc4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23709753","rdfs:label":"I","family":{"id":"https://genegraph.clinicalgenome.org/r/b7c752f1-6007-48cd-8d17-4ed7e2b62bc4","type":"Family","rdfs:label":"I","member":{"id":"https://genegraph.clinicalgenome.org/r/37020c6b-211f-45fb-97a2-427061d82baa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23709753","rdfs:label":"I1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":66,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5d7d1da3-2eea-43aa-9679-083b339e863c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.137G>T (p.Ser46Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA009597"}},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/05fe0f88-9595-47f1-9044-679b03c5d3dd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23709753","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d7d1da3-2eea-43aa-9679-083b339e863c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/37020c6b-211f-45fb-97a2-427061d82baa"}},{"id":"https://genegraph.clinicalgenome.org/r/d9202fc7-7cf1-44c0-8245-70cdd7ff53bc_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations in AD condition","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31860975","rdfs:label":"case report","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/d9202fc7-7cf1-44c0-8245-70cdd7ff53bc","type":"Family","rdfs:label":"case report","member":{"id":"https://genegraph.clinicalgenome.org/r/610e4240-3c45-45b1-a9e7-929d4a25643f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31860975","rdfs:label":"26-year-old Chinese female patient ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f5aeaee0-586b-4c37-8a99-aa5e55d6572c"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d13eee9c-8355-42bd-8d20-7ab7d1319838_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/610e4240-3c45-45b1-a9e7-929d4a25643f"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/931575bf-96bb-44a6-8bf7-b4512f96ea53","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/931575bf-96bb-44a6-8bf7-b4512f96ea53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27435373","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d7d1da3-2eea-43aa-9679-083b339e863c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/931575bf-96bb-44a6-8bf7-b4512f96ea53_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"showed MMR deficiency in the in vitro functional MMR assays (Figure 5). This missense variant is classified by InSiGHT as likely pathogenic justified by deficient MMR shown by two independent assays (Borras et al., 2013; Drost et al., 2013) and by the fact that this variant is found worldwide in several Lynch syndrome and CMMRD patients with tumors showing an MSI High and/or isolated PMS2 loss phenotype. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6f9d9428-448f-4fe8-bf94-c5377eb90693","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f9d9428-448f-4fe8-bf94-c5377eb90693_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16619239","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f75f025-a278-401f-ab53-db5e70dd4479","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.2007-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA010684"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6f9d9428-448f-4fe8-bf94-c5377eb90693_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Negative PMS2 IHC","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/05fe0f88-9595-47f1-9044-679b03c5d3dd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05fe0f88-9595-47f1-9044-679b03c5d3dd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/05fe0f88-9595-47f1-9044-679b03c5d3dd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional assays at the protein level demonstrated that c.137G>T (p.S46I) significantly impairs MMR activity.\n\nthe MMR assay showed a significantly reduced MMR activity for c.137G>T (p.S46I) variant (12.75%±4.68) Figure 3\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea335968-cd3a-4481-bb92-e5b45ed14778","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea335968-cd3a-4481-bb92-e5b45ed14778_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16619239","allele":{"id":"https://genegraph.clinicalgenome.org/r/f7614ed6-bfd7-4d3a-a822-69118e0f4612","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.6(PMS2):c.736_741delCCCCCTins11 (p.?)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/141845"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/ea335968-cd3a-4481-bb92-e5b45ed14778_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Negative IHC (Table 2)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3464f64d-2051-478f-9817-116436b60de2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3464f64d-2051-478f-9817-116436b60de2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8072530","allele":{"id":"https://genegraph.clinicalgenome.org/r/1532604a-cdf9-4350-85d6-b7ff06dde74d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.6(PMS2):c.804-?_2006+?del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/91373"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/61045b20-f3d1-452d-a685-5d2df62e6c4f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61045b20-f3d1-452d-a685-5d2df62e6c4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16619239","allele":{"id":"https://genegraph.clinicalgenome.org/r/f7614ed6-bfd7-4d3a-a822-69118e0f4612"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/61045b20-f3d1-452d-a685-5d2df62e6c4f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Negative IHC","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/71da4f7c-8493-4cc7-83b8-374769367c25","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71da4f7c-8493-4cc7-83b8-374769367c25_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23012243","allele":{"id":"https://genegraph.clinicalgenome.org/r/418e5568-76e2-4d36-9913-0cba79fd1f8d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.6(PMS2):c.2276-?_2445+?del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/267344"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/71da4f7c-8493-4cc7-83b8-374769367c25_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"IHC: PMS2 absent","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c86e3b4-1420-410f-abe9-2ad14c31ca6d","type":"EvidenceLine","dc:description":"No score because heterozygous PMS2 mutation carriers were at small increased risk for colorectal and endometrial cancer but not for any other Lynch syndrome–associated cancer. In total, 284 families consisting of 4,878 first- and second-degree family members were included in the analysis. PMS2 mutation carriers were at increased risk for colorectal cancer (cumulative risk to age 80 years of 13% [95% CI, 7.9% to 22%] for males and 12% [95% CI, 6.7% to 21%] for females) and endometrial cancer (13% [95% CI, 7.0%–24%]), compared with the general population (6.6%, 4.7%, and 2.4%, respectively). There was no clear evidence of an increased risk of ovarian, gastric, hepatobiliary, bladder, renal, brain, breast, prostate, or small bowel cancer.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c86e3b4-1420-410f-abe9-2ad14c31ca6d_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30161022","rdfs:label":"Cancer Risks for PMS2-Associated Lynch Syndrome","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/99c40329-7bf6-45a9-9771-cb6e1502bf8a","type":"Cohort","allGenotypedSequenced":513,"alleleFrequency":1,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c86e3b4-1420-410f-abe9-2ad14c31ca6d_cc_evidence_item"}],"numWithVariant":513,"relatedCondition":{"id":"obo:MONDO_0005835"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/2396944f-26aa-4877-b332-40e74a50223b","type":"Cohort","allGenotypedSequenced":404,"alleleFrequency":0,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c86e3b4-1420-410f-abe9-2ad14c31ca6d_cc_evidence_item"}],"numWithVariant":0},"method":{"id":"cg:AggregateVariantAnalysis"},"statisticalSignificanceType":"hazard ratios (HRs) and age-specific cumulative risks (penetrance)","statisticalSignificanceValueType":"Other"}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0502b6ff-77d7-4083-b8e5-7f0c6bfa0a1f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0502b6ff-77d7-4083-b8e5-7f0c6bfa0a1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16619239","allele":{"id":"https://genegraph.clinicalgenome.org/r/143adf4e-1509-494b-8ec1-b8b273f2c592","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.862_863del (p.Gln288fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA013065"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0502b6ff-77d7-4083-b8e5-7f0c6bfa0a1f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Negative PMS2 IHC","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/63b2c323-4138-475f-92de-2b711a10a99b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63b2c323-4138-475f-92de-2b711a10a99b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23012243","allele":{"id":"https://genegraph.clinicalgenome.org/r/418e5568-76e2-4d36-9913-0cba79fd1f8d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/63b2c323-4138-475f-92de-2b711a10a99b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"IHC: PMS2 absent","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/53ff84c4-a229-4d87-bfae-36520f814619","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53ff84c4-a229-4d87-bfae-36520f814619_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16619239","allele":{"id":"https://genegraph.clinicalgenome.org/r/f7614ed6-bfd7-4d3a-a822-69118e0f4612"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/53ff84c4-a229-4d87-bfae-36520f814619_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"negative IHC","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a1603380-faad-46c0-81d8-dd3bb5037dc7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1603380-faad-46c0-81d8-dd3bb5037dc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27435373","allele":{"id":"https://genegraph.clinicalgenome.org/r/b74040e4-5003-4043-9c3a-fa9f2fad1080","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000535.7(PMS2):c.903G>T (p.Lys301Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA013203"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a1603380-faad-46c0-81d8-dd3bb5037dc7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Patient RNA showed 100% skip of exon 8 indicated by the absence of the variant c.903T in the wildtype transcript; minigene splice assay showed absence of full-length transcripts from variant allele (van der Klift et al., 2015). Table 1: r.804_903de l (out of frame skip of exon 8, NMD).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9643f75d-d9bc-4b45-b022-71e143873f79","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9643f75d-d9bc-4b45-b022-71e143873f79_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f87831b-69b3-463c-a8db-c32aee89269f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5a9e3d0-8195-4722-b09c-9e55a6fc92f7","type":"Finding","dc:description":"several Lynch syndrome and CMMRD patients with tumors show isolated PMS2 loss phenotype. PMS2 c.825A>G caused skipping of the first 22 nucleotides of exon 8.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27435373","rdfs:label":"RNA analysis","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e0771b2d-46a5-439e-8d13-dae160589eb6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df90e412-318c-4b16-928a-b99599925eb3","type":"Finding","dc:description":"several Lynch syndrome and CMMRD patients with tumors show isolated PMS2 loss phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27435373","rdfs:label":"RNA analysis","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e69e2a86-0ce7-485a-9bf0-bf7989dc8d4f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f7b6b35-ecc3-4677-942e-44e1c0de2c24","type":"Finding","dc:description":"all are mismatch repair (MMR) genes","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24027009","rdfs:label":"in vitro MMR activity using modified cell free assay","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/213ba61e-a4a5-4e4f-945d-f0fef691a9ba_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6708c826-0a6a-4b2d-990c-86e0a043aaae","type":"EvidenceLine","dc:description":"Reduced score because study focused on KI/KI and KO mice and not on the KI/+ mice (Lynch syndrome is AD). Only one polyp was found in the KI/+ mice. Score of 1 given because authors generated mice with an equivalent germline mutation (Pms2c.1993A>G) and demonstrate that it results in a splicing defect similar to those observed in humans. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/376bd12c-ebba-4165-ba06-c87245bcbdad","type":"Finding","dc:description":"The human and mouse PMS2 proteins share a high homology in their amino acid sequence. Authors have generated mice with an equivalent germline mutation (Pms2c.1993A>G) and demonstrate that it results in a splicing defect similar to those observed in humans. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20624957","rdfs:label":"Endonuclease-deficient Pms2-E702K knock-in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9c882a7c-e3c3-4d43-809c-d914760e3b57","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e799a708-b031-4250-a769-46feab642ab6","type":"Finding","dc:description":"When treated with exogenous carcinogen 50 mg N-methyl-N-nitrosourea (MNU)/ kg i.p when 5 weeks old, PMS2+/- mice were significantly more likely to develop intestinal tumors — both adenomas and adenocarcinomas -- than PMS2+/+ mice. The intestinal tumors were located mainly in the small intestine. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10753224","rdfs:label":"HET PMS2-KO susceptible to intestinal tumor with carcinogen","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e049b956-edc3-4b17-b7dd-a1540e6dbd7b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e47e3a7a-2769-4c68-a9ea-05c0104a5bde","type":"Finding","dc:description":"Germline variant results in an attenuated form of both CMMRD in homozygous state and Lynch Syndrome in heterozygotes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34489406","rdfs:label":"Mouse knock-in Pms2 c.1993A>G equivalent to human c.2002A>G","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":5619,"specifiedBy":"GeneValidityCriteria9","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ZpXzqG9RX58","type":"GeneValidityProposition","disease":"obo:MONDO_0005835","gene":"hgnc:9122","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_213ba61e-a4a5-4e4f-945d-f0fef691a9ba-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}